Presented in part at the 154th annual meeting of the American Psychiatric Association, New Orleans, May 5–10, 2001; the annual meeting of the Society for Biological Psychiatry, San Francisco, May 17, 2003; the International Congress on Schizophrenia Research, Whistler, B.C., Canada, May 2001; and the 40th annual meeting of the American College of Neuropsychopharmacology, Hawaii, December 2001. Received Feb. 21, 2004; revision received April 17, 2004; accepted May 10, 2004. From the Department of Psychiatry and Biobehavioral Sciences, the David Geffen School of Medicine, University of California at Los Angeles; the Department of Psychiatry, Greater Los Angeles VA Healthcare System; the Department of Psychology, California State University at Northridge, Northridge, Calif. Address correspondence and reprint requests to Dr. Mintz, Greater Los Angeles VA Healthcare System, 11301 Wilshire Blvd. (116AR), Los Angeles, CA 90073; firstname.lastname@example.org (e-mail). The authors thank William C. Wirshing, Mark Frye, Lori Altshuler, Michael Green, Stephen Marder, Keith Nuechterlein, Joseph Pierre, and John Kobashigawa for referring study participants; Jennifer Boyd, Robert Kern, R.P. Liberman, C.J. Wallace, the National Alliance for the Mentally Ill, the National Alliance for Research on Schizophrenia and Depression, Lois Mintz, and William C. Wirshing for contributing to the development of the video program; Joseph Ventura and Helen Lu for testing and recruiting patients; Sun Hwang for statistical support; and Seth Resnick and Shirley Mena for assisting with manuscript preparation. Supported by NIMH grant R01-MH-68100-02 to Jim Mintz.